Listed

Lite Strategy, Inc.

LITSNasdaqCIK 1262104FinancialsFiscal year ends Jun 30

Latest reported revenue, Q4 FY2025$0Revenue, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-09-26, accession 0001193125-25-220421. Derived: 12-month figure less the 9-month figure.Report this figureThree months to Jun 30, 2025, from the 10-K filed Sep 26, 2025.

Latest quarter: Q4 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenuenot reported (Revenue not reported)No year-earlier figure to compare
  • Gross marginnot reported (Gross profit and Revenue not reported)No year-earlier figure to compare
  • Operating marginnot reported (Revenue not reported)No year-earlier figure to compare
  • Net marginnot reported (Revenue not reported)No year-earlier figure to compare
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$0, Q4 FY2025
Diluted EPS−$0.66, Q3 FY2026
Free cash flow−$2.5m, Q4 FY2025
Lite Strategy, Inc., key figures for the last eight quarters
Line itemUnitQ1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30Shape over the periods
Revenue$k0.0Revenue, Q1 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0000950170-24-125328.Report this figure0.0Revenue, Q2 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-02-12, accession 0000950170-25-018809.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0000950170-25-070276.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-09-26, accession 0001193125-25-220421. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)
Operating margin%not reported (Revenue of zero not reported)not reported (Revenue of zero not reported)not reported (Revenue of zero not reported)not reported (Revenue of zero not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Net margin%not reported (Revenue of zero not reported)not reported (Revenue of zero not reported)not reported (Revenue of zero not reported)not reported (Revenue of zero not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Diluted EPS$ per share(1.20)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283111.Report this figure(0.40)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001193125-26-053215.Report this figure(0.39)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220687.Report this figurenot reported (Diluted EPS not reported)(0.12)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-283111.Report this figure(0.82)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001193125-26-053215.Report this figure(0.66)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220687.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)(3,267)Free cash flow, Q3 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220687. Derived: 9-month figure less the 6-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070276. Derived: 9-month figure less the 6-month figure.Report this figure(2,461)Free cash flow, Q4 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001193125-26-405328. Derived: 12-month figure less the 9-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-26, accession 0001193125-25-220421. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$0Operating margin not reported
Diluted EPS−$2.06, FY2026
Free cash flow−$20.8m, FY2025
Lite Strategy, Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$m40.7Revenue, FY2022, twelve months to 2022-06-30$40.7m. XBRL concept us-gaap:Revenues. 10-K filed 2023-09-26, accession 0000950170-23-049927.Report this figure48.8Revenue, FY2023, twelve months to 2023-06-30$48.8m. XBRL concept us-gaap:Revenues. 10-K filed 2024-09-19, accession 0000950170-24-108185.Report this figure65.3Revenue, FY2024, twelve months to 2024-06-30$65.3m. XBRL concept us-gaap:Revenues. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figure0.0Revenue, FY2025, twelve months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figurenot reported (Revenue not reported)
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit and Revenue not reported)
Operating margin%(185.5%)Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: −$75.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-09-26, accession 0000950170-23-049927.Revenue: $40.7m. XBRL concept us-gaap:Revenues. 10-K filed 2023-09-26, accession 0000950170-23-049927.Report this figure(75.3%)Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: −$36.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-09-19, accession 0000950170-24-108185.Revenue: $48.8m. XBRL concept us-gaap:Revenues. 10-K filed 2024-09-19, accession 0000950170-24-108185.Report this figure22.3%Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: $14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-26, accession 0001193125-25-220421.Revenue: $65.3m. XBRL concept us-gaap:Revenues. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figurenot reported (Revenue of zero not reported)not reported (Revenue not reported)
Net margin%(132.7%)Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: −$54.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2023-10-27, accession 0000950170-23-055978.Revenue: $40.7m. XBRL concept us-gaap:Revenues. 10-K filed 2023-09-26, accession 0000950170-23-049927.Report this figure(65.6%)Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: −$32.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-26, accession 0001193125-25-220421.Revenue: $48.8m. XBRL concept us-gaap:Revenues. 10-K filed 2024-09-19, accession 0000950170-24-108185.Report this figure27.6%Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: $18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001193125-26-405328.Revenue: $65.3m. XBRL concept us-gaap:Revenues. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figurenot reported (Revenue of zero not reported)not reported (Revenue not reported)
Diluted EPS$ per share(9.99)Diluted EPS, FY2022, twelve months to 2022-06-30−$9.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-09-26, accession 0000950170-23-049927.Report this figure(4.78)Diluted EPS, FY2023, twelve months to 2023-06-30−$4.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-09-19, accession 0000950170-24-108185.Report this figure2.67Diluted EPS, FY2024, twelve months to 2024-06-30$2.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figure(2.39)Diluted EPS, FY2025, twelve months to 2025-06-30−$2.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-09-28, accession 0001193125-26-405328.Report this figure(2.06)Diluted EPS, FY2026, twelve months to 2026-06-30−$2.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-09-28, accession 0001193125-26-405328.Report this figure
Free cash flow$m(49.2)Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: −$48.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-09-26, accession 0000950170-23-049927.Capital expenditure: $479.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-09-26, accession 0000950170-23-049927.Report this figure(52.5)Free cash flow, FY2023, twelve months to 2023-06-30. operating cash flow − capital expenditureOperating cash flow: −$52.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-09-19, accession 0000950170-24-108185.Capital expenditure: $35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-09-26, accession 0000950170-23-049927.Report this figure(50.5)Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: −$50.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-26, accession 0001193125-25-220421.Capital expenditure: $7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figure(20.8)Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001193125-26-405328.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-26, accession 0001193125-25-220421.Report this figurenot reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $12.6kSales $0
Lite Strategy, Inc., open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2025-07-23Glover NicholasDirector Purchase1,000$6.00$6.0kForm 4
2025-07-22Glover NicholasDirector Purchase1,000$6.55$6.5kForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Lite Strategy, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
RENAISSANCE TECHNOLOGIES LLC2026-06-30$1.2m1,247,350Reduced−497,350
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$942.2k1,021,892Reduced−21,421
RLH Capital LLC2026-06-30$743.9k806,433New+806,433
CITADEL ADVISORS LLC2026-06-30$562.4k609,700CallAdded+572,300
TWO SIGMA INVESTMENTS, LP2026-06-30$513.8k557,011Reduced−57,431
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$337.1k365,019Reduced−36,072
CITADEL ADVISORS LLC2026-06-30$329.8k357,529Reduced−372,570
BlackRock, Inc.2026-06-30$254.4k275,829Added+117,938
MARSHALL WACE, LLP2026-06-30$214.3k232,979Reduced−100,529
VANGUARD FIDUCIARY TRUST CO2026-06-30$180.2k195,392Added+1,397

Recent filings

All 900 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Lite Strategy, Inc., recent filings
FiledFormWhat it isAccession number
2026-09-2816:10 ET10-KAnnual reportPeriod 2026-06-300001193125-26-405328
2026-07-3008:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-325026
2026-07-2417:29 ET8-K7.01 Regulation FD disclosure0001193125-26-316284
2026-05-1308:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-220697
2026-05-1308:30 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-220687
2026-02-1708:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-053243
2026-02-1708:45 ET10-QQuarterly reportPeriod 2025-12-310001193125-26-053215
2026-02-1217:10 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-26-049005
2025-12-3016:00 ETDEF 14AProxy statementPeriod 2025-12-300001193125-25-337041
2025-12-3006:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-25-335761

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Sep 28, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1262104
Tickers
LITS
Exchange
Nasdaq
SIC code
6199 Finance Services
Sector
Financials
Fiscal year ends
Jun 30
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
MEI Pharma, Inc. (to 2025-09-10); MARSHALL EDWARDS INC (to 2012-06-06)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.